Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2019
|
| In: |
Clinical trials
Year: 2018, Volume: 16, Issue: 1, Pages: 20-31 |
| ISSN: | 1740-7753 |
| DOI: | 10.1177/1740774518807160 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1177/1740774518807160 Verlag, Volltext: https://jhu.pure.elsevier.com/en/publications/developing-a-risk-based-composite-neurologic-outcome-for-a-trial- 
|
| Author Notes: | James F. Casella, Robert J. Adams, Donald J. Brambilla, John Strouse, Pia Maier, Rachel Dlugash, Radhika Avadhani, Krista Vermillion, James A. Tonascia, Jenifer H. Voeks, Daniel F. Hanley, Richard Thompson, and Harold P. Lehmann; for the HU Prevent Investigators |
| Item Description: | First published November 14, 2018 Gesehen am 29.03.2019 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1740-7753 |
| DOI: | 10.1177/1740774518807160 |